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A previously uncharacterized population of class II antigen-
bearing dendritic cells that are intimately associated with the 
dermal microvasculature was identified in normal human 
skin using a double-label, indirect immunofluorescence tech-
nique. The only other major HLA-DR positive dermal cell 
type noted in these studies, the dermal microvascular endo-
thelial cell (DMVEC), appeared to express lesser amounts of 
HLA-DR region gene product than did this dermal perivas-
cular dendritic cell (DPDC). These DPDC were particularly 
common around small vessels in the superficial vascular 
plexus of the papillary dermis and were distinct from the mast 
cell, another cell type normally seen in a similar location. 
hile using a double label. indirect immunoflu-
orescence technique to examine the class II 
histocompatibility antigen-expressing capac-
ity of human dermal microvascular endothe-
lial cells (DMVEC) in situ, we were surprised 
to find a previously unrecognized population of perivascular den-
dritic cells that appeared to displ ay greater amounts of HLA-DR 
antigen than the endothelial cells with which they were intimately 
associated [1]. Others have commented upon a class II antigen posi-
tive. dendritic-appearing cell in normal adu lt [2] and fetal [3] human 
dermis; however, such cell s have previously been fe lt to be rather 
randomly distributed throughout this tissue. In addition, a ce ll hav-
ing a veiled morphology has also been noted to surround nonle-
sional human dermal microvessels [4]. While data regarding this 
latter cell type's ability to express HLA-D region antigens have not 
yet been formally presented, very recent observations have sug-
gested that it might be capable of doing so (personal communica-
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Abbreviations: 
DMVEC: dermal microvascular endothe lial cell (s) 
DPDC: dermal perivascular dendritic ce ll (5) 
DPDM: dermal perivascular dendritic macrophage (5) 
FITC: fluorescein isothiocyanate 
PBS: phosphate buffered saline 
TRITC: tetramethyl rhodamine isothiocyanate 
Phenotypic and ultrastructural studies have determined that 
the DPDC is more closely related to the monocyte/macro-
phage lineage than the dendritic cell lineage. The perivascu-
lar location and phenotype of this cell distinguishes it from 
other previously described constitutive dermal cell types such 
as the classic " histiocyte," veiled cell, and dendrocyte. The 
relatively rich expression of all three major HLA-D region 
gene products by this dermal perivascular dendritic macro-
phage would suggest that it could playa significant role in the 
immunobiology of the dermal microvascular unit. J. Invest 
DermatoI93:154-159,1989 
tions, Dr. I.M. Braverman). If this perivascular veil cell is confirmed 
to constitutively express class II histocompatibility antigens, it 
would be closely related to the cell that we have observed in the 
current study. Both the dermal histiocyte and veil cell have been felt 
by some to be related to the fibroblast lineage [2,4]. Because the 
dermal perivascular dendritic cell (DPDC) which we have observed 
in the present study appears to have a macrophage rather than fi-
broblast phenotype. it was our impression that this cell has not yet 
been formally studied. Therefore, we initiated a systematic exami-
nation of the phenotypic and ultrastructural characteristics of this 
previously uncharacterized cell type. 
MATERIALS AND METHODS 
Tissue Source Normal human skin specimens from three ana-
tomical regions were examined in this study: 1) abdominal wall skin 
taken from the edge of excised Cesarean section scars removed from 
healthy adu lt multiparous females (n = 20), 2) newborn foreskin 
(n = 12), and 3) normal adu lt male deltoid skin (n = 6). 
Double Label Indirect Immunofluorescence Technique 
Freshly obtained skin specimens were trimmed, embedded in 
O .C.T. compound embedding medium ("Tissue-Tek." Miles Sci-
entific. Naperville, IL), and snap frozen in liquid nitrogen. Four 
micron vertical sections were prepared, applied to a clean glass slide, 
and fixed by a 5 min immersion in 100% acetone. The sections were 
then exposed to one of the following three combinations of lectins, 
monoclonal antibodies, and fluorochrome conjugated antisera: 1) 
Rabbit anti-human factor VIII antiserum (1 :20 dilution) (Dako Co., 
Santa Barbara, CA) followed by tetramethyl rhodamine iso-
thiocyanate {TRITC)-conjugated goat anti-rabbit IgG antiserum 
(1:20) (Cappel, Cochranville, PA) followed by murine monoclonal 
antibody (1:10) (see types and sources in Table I) followed by fluo-
rescein isothiocyanate {FITC)-col~ugated goat anti-mouse IgG an-
tiserum (1 :20) (Cappel); 2) FITC-conjugated Ulex europeus lectin. 
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Table I. Immunologic Phenotype of a Human D ermal Perivascular Dendritic Cell 
Monoclonal Antibod ies and Lectins Specific ity Cellular Reactivity" Source' Result' 
Class II Antigens 
L243 HLA-OR 1 +++ 
FA HLA-OP 2 + 
Leu- l0, Tu-22 HLA-OQ 1,2 + 
Langerhans cell 
OKT-6 CO l a ELC, Thym. 3 
Mast ce ll 
Avidin Mast cells 4 
T cell 
OKT-3 C03 T cells 3 
OKT-4 C04 T subset 3 
OKT-8 C08 T subset 3 
B cell 
B-1 C020 B cells S 
CR2 (C3dR) C021 B cells, FORC 
N Kcell 
Leu-7 (HNK-l) NK 
Leu-II CO l 6 Nk, PMN 
Monocyte/ macrophage 
OKM-l (CR3, MAC- I, Mo-l) COllb Mo,Mp, PMN 3 + 
Leu-MS (pISO,9S) COlle Mo, PMN 1 + 
6303 Mo, Mp 2 + 
H7.10 Mo, Mp 2 + 
H38.1A Mo, Mp 2 + 
OKM-S Mo, Mp, Plat. 3 
Mo-2 C014 Mo, FORC S 
CR1 CD3S Mo, Mp,PMN I 
2SF9 tissue Mp 6 
13 other 
monocyte-specific 
monoclonals Mo,Mp 2 
Miscellaneous 
HLe-l C04S Cells of bone 
marrow ongm + 
7C4 CO lb 7 
7C6 COl e B cells, DOC 7 
• ELC: epidermal Langerhans cells; thym: cortical thymocytes; NK: natural killer cells; PMN: polymorpho-
nuciear nuciear leukocytes; Mo: monocytes; Mp: macrophages; FDRC: follicular dendritic reticulum cell s; 
DOC: dermal dendritic cells; Plat: platlets. 
b 1: Beckton Dickinson (Mountain View, CAl; 2: Gift from Dr. Peter Stastny (Dept. of Dermatology, Univ. 
of Texas Southwestern Medica l Center, Dallas, TX); 3: Ortho Diagnostic Systems (Raritan, NJ); 4: 
Boehringer Mannheim Biochemicals (Indianapolis, IN); 5: Coulter Immunology (Hialeah, FL); 6: Gift from 
Dr. Bettina Mues and Dr. C. Sorg (Munster, Wester Germany); 7: Prof. Dr. W. Knapp (Third International 
Workshop on Human Leukocyte Differentiation Antigens), courtesy of Dr. Jack Longley (Department of 
Dermatology, Yale University School of Medicine). 
,+++: strong fluorescence intensity; +: weak fluorescence intensity; -: no specific fluorescence. 
an endothelial cell marker [5] , (100 ,ug/ml) (Vector Labs, Burlin-
game, CA) followed by monoclonal antibody (1:10) (Table I) fol-
lowed by ,TRITC-conjugated goat anti-mouse IgG antiserum 
(1: 20) (Cappel) ; 3) FITC-avidin, a mast cell marker [6] (1 :100) 
(Boehringer M annheim, Indianapolis, IN) followed by murine 
monoclonal anti-HLA-DR, L243 (1:10) (Beckton D ickinson, 
Mountain View, CA) followed by TRITC-goat anti-mouse IgG 
antiserum (1 :20) (Cappel) . 
Each reagent was diluted in phosphate buffered saline (PBS) and 
applied to the tissue sections for 30 min in a humidified environ-
ment. The sections were then washed thoroughly in PBS after each 
incubation and examined and photographed with a Leitz Orthoplan 
fluorescence microscope equipped for epi-i llumination. 
The appropriate controls revealed that there was no cross-reactiv-
ity between the goat anti-mouse IgG and the rabbit anti-human 
factor VIn antisera. In addition, no specific fluorescence was de-
tected in skin sections incubated with any of the fluorochrome 
conjugated antisera used alone. 
Peroxidase-Anti peroxidase Technique for Light and Elec-
tron Microscopy Cutaneous tissue was fixed in 2% periodate- ly-
sine-paraformaldehyde for 90 min at 4 ° C. The tissue was then 
w ashed in PBS for 2 h at 4 °C and imbedded in OCT mounting 
medium fo llowed by snap freezing in liquid nitrogen. At this point 
the tissue was either stored at - 70 ° C or further processed inunedi-
ate ly. Four-micron vertical frozen sections were prepared and 
p laced on 1 % gelatin coated slides. The slides were then air dried 
and incubated with a 1: 10 dilution of the primary mouse monoclo-
nal antibody (L243) for 30 min at room temperature. They were 
then w ashed 3 times in PBS (5 min for each wash) and further 
incubated in a goat anti-mouse IgG antiserum (1:20) for 30 min at 
room temperature followed by another wash in PBS 3 times. Mouse 
peroxidase anti-peroxidase (Jackson Laboratories, Avondale, PA) 
(1: 25 dilution) w as then applied to the slides for 30 min at room 
temperature fo llowed again by washing 3 times. The sections were 
then covered with 2.5% glutaraldehyde for 1 h at 4 °C followed by 
another w ash in PBS 3 times. They were then developed in 0.05% 
diaminobellzidille for 15 min in the dark followed by another wash 
in PBS 3 times. The slides were then covered with 1% osmium 
tetroxide for 1 h at 4 ° C and then again washed in PBS 3 times. The 
sections were then dehydrated by sequential 15-min immersions in 
70%,85%,90%, and 95% ethanol. T hey were then soaked in 100% 
ethanol for 1 h , changing the ethanol every 20 min. Liquified 
Epoll-filled cassettes were then inverted over the sections on the 
slides. T he Epon was allowed to harden for 3 d at 60 °C. The slides, 
with the solidified, Epon-filled cassettes attached, were then im-
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mersed in li.quid nitrogen to facilitate separation of the Epon-em-
bedded sectIOns from the glass surface. Both unstained and lead 
citrate stained, ultrathin sections were then examined with a Joel 




Figure 1. A: Immunofluorescence micrograph of normal human abdomi-
nal wall skin processed with reagent combination 1 in Materials OIld Methods 
to simultaneously demonstrate the presence of factor VIII and HLA-DR 
antigens. This preparation was viewed and photographed under FITC exci-
tation filters. N ote the HLA-DR positive dendritic cells (FITC) (arrowheads) 
surrounding the HLA-DR and factor VlII positive endothelial cells of der-
mal microvessels in cross section (FITC and TRITC) (asterisks) . The' der-
mal-epidermal junction is indicated by the white Iitle. This single exposure 
micrograph has the appearance of a double exposure due to the fact that some 
TRITC fluo rescence does occur and "bleeds through" with FITC excitation 
wavelengths. B : Longitudinal section of a papillary dermis microvessel 
stained, photographed, and labeled as inA . Note virtual conduitofHLA-DR 
expressing perivascular dendritic cells (arrowh eads) surrounding HLA-DR 
and factor VIII positive endothelial ce lls (asterisks) . C: Same field as in B 
photographed under TRITC excitation filters. Only tubular red fluores-
cence of the factor VIII positive endothelial cell channel is seen (asterisks) . 
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RESULTS 
Phenotype of the DPDC These studies have shown that there 
are two morphologically distinct, class II antigen positive cells 
which are normally resident in human dermis: the microvascular 
endothelial cell and a dendritic cell predominately located in the 
immediate perivascular space. Figure IA,B illustrates the appear-
ance of this second cell type. These HLA-DR positive cells were 
seen in greatest density in the upper papillary dermis. Their appear-
ance was the same when either factor VIII or Ulex europeus was used 
to mark the presence of endothelial cells. While Ulex binds to both 
lymphatic and vascular endothelial cells, factor VIII is expressed 
predominately by vascular endothelial cells [7]. Because the appear-
ance and density of DPDC around Ulex and anti-factor VIII posi-
tive endothelial cells was quite similar, we feel that this cell type is 
primarily associated with the microvasculature rather than small 
lymphatic vessels. However, this point needs to be more closely 
examined. 
As seen in Fig IB, the DPDC in some sections appeared to almost 
form a conduit around the microvessels in this location. However, 
the bodies of these cells did not appear to be in direct physical 
contact with the vessel wall, supporting the argument against the 
possibility that they are pericytes. Direct apposition of HLA-DR 
positive perivascular cells to endothelial cells was also not observed 
in the immunoelectron microscopy studies. The possibility that the 
dendritic processes of these cells might be actually touching the 
vessel wall cannot be excluded from our studies to date. 
The striking perivascular array of these cells was less evident in 
the reticular dermis and subcutaneous tissue. It is our current im-
pression that much lower densities of D PDC exist in these two areas 
compared with the papillary dermis. This could relate to lower 
densities of microvessels in these deeper areas compared with the 
superficial vascular plexus. We are currently examining these issues 
with a quantitative, morphometric point-counting technique. 
The appearance and density of DPOC did not vary significantly 
in numerous individual specimens of the three types of normal skin 
examined in this study, except for the possibility that they could be 
somewhat more numerous in the pregnancy abdominal wall skin. 
While serial sections were not systematically examined in this in-
vestigation, it was our impression that a large majority of the class II 
antigen-positive dendritic cells present in the dermis were in fact 
closely associated with microvessels. 
The perivascular location of these cells suggested the possibility 
that they might be related to mast cells, another cell type normally 
present in this location. However, examination of skin sections 
treated with FITC avidin, a mast cell marker [6], followed by a 
combination of reagents to mark the presence of HLA-DR antigen 
(combination 3 in Materials alld Methods), revealed that DPDC and 
dermal mast cells were completely separate cell populations (data 
not shown). This experiment also confirmed that at least a majority 
of dermal mast cells do not express enough HLA-OR antigen in situ 
to be detected by immunofluorescence microscopy. While we did 
not attempt to quantitate the density of mast cells in this study, the 
number of DPDC appeared to be equal to or perhaps even greater 
than that of mast cells. 
Because we initially identified the OPOC by its expression of 
large amounts of HLA-DR antigen, molecles present in high den-
sity on the surface of several cell types involved in the immune 
response, we chose to further examine this cell for other phenotypic 
markers displ ayed by immunocompetent cells. Table llists the mur-
ine monoclonal antibodies and lectins that were used to further 
probe the identity of this cell type. 
The pattern of reactivity observed suggests that these cells are of 
bone marrow origin but are not fully mature epidermal Langerhans 
cells because they did not express CDla (OKT-6). The presence of 
epidermal dendritic cells in the same section served as a positive 
control for the OKT-6 monoclonal antibody. The possibility that 
DPOC might represent dermal Langerhans cells, which have not 
yet expressed the CDla determinant, on their way to the epidermis 
cannot be completely excluded, even though the ultrastructural 
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appearance of the DPDC (see below) was different from that of the 
epidermal Langerhans cell. Recent observations by others have sug-
gested that the epidermis and cytokines produced by epidermal 
keratinocytes such as IL-l may be able to induce the expression of 
CDla on cells that were previously negative for this phenotype 
[8 - 9]. In addition, other investigations have suggested that messen-
ger RNA coding for related molecules in this gene family such as 
CDlc might be expressed on a population of dermal dendritic cells 
[10]. Likewise, van de Rijn et al [11] have reported that the CDlc 
determinant is expressed in human skin predominately on perivas-
cular cells in the dermis. However, in our studies, the HLA-DR 
positive dermal perivascular dendritic cells which expressed several 
macrophage markers did not react with a different CDlc monoclo-
nal antibody. This specificity (7C6) bound only to scattered cells in 
the upper dermis just below the dermal-epidermal junction. A re-
lated monoclonal antibody specific for CDlb (7C4) did not react 
with any cutaneous cell type in our studies. 
The HLA-DR positive DPDC did not bind T-cell, B-cell, or 
NK-cell reactive monoclonal antibodies. However, they did react 
with HLA-DP -DQ specifications, and several monocyte/macro-
phage reactive antibodies (Leu-MS, 63D3, OKM-l). All DPDC 
appeared to express HLA-DQ determinants, which are present on 
only about 50% of circulating monocytes [12] . The fluorescence 
intensity was quite weak with all antibodies except the HLA-DR 
specificity, L243. It is thus possible that the failure of the other 
macrophage-specific monoclonals, such as Mo-2, to bind to DPDC 
could relate to the relative insensitivity of the immunofluorescence 
technique used in this study. It is also possible that these perivascular 
macrophages, like other tissue macrophages, do not express this 
particular monocyte determinant [13] . 
Ultrastructural Characteristics ofDPDC To further charac-
terize the identity of DPDC, immunoperoxidase electron micros-
copy was carried out. Figure 2 represents the appearance of normal 
abdominal wall skin that was reacted with the HLA-DR specific 
monoclonal antibody L243, followed by a peroxidase-antiperoxi-
dase visualization technique. Several cells having dark peroxidase 
reaction product on their surfaces can be seen surrounding a micro-
vessel, whose endothelial cells are not associated with the reaction 
product. This supports our observation, using the indirect immuno-
flu orescence technique, that these perivascular dendritic cells ex-
press relatively greater amounts ofHLA-DR antigen than DMVEC 
and raises the possibility that heterogeneity might exist with respect 
to class II antigen expression by different types of dermalmicroves-
sels. Recent studies have suggested that certain activation determi-
nants are expressed on only dermal post capillary venular endothe-
lial cells [14] . Studies which are in progress in our lab have also 
suggested that significant variation exists in the degree of HLA-D 
region antigen expression by Ulex positive dermal endothelial cell 
subpopulations freshly isolated from the same skin specimen (per-
sonal unpubJ'ished observation). 
Figure 3 illustrates the ultrastructural characteristics of DPDC. 
These cells have a distinctive folded nucleus and a highly ruffled, 
irregular surface. In the lead citrate counterstained sections, rela-
tively dark cytoplasm containing mitochondria and an occasional 
lysosome was seen. Birbeck granules were not observed. In the 
unstained sections, HLA-DR antigen was found predominately on 
the plasma membrane. The appearance of this cell is highly reminis-
cent of the classic dermal histiocyte which has been noted to be 
present in the perivascular space by others [15] . However, most 
workers have felt that histiocytes are randomly distributed 
throughout the dennis. 
DISCUSSION 
The concept of the existence 'of a population of constitutive, ran-
domly-distributed dermal mononuclear cells, variously referred to 
as histiocytes, dendrocytes, or dendritic cells, is certainly not a new 
one. There is, however, an ongoing debate regarding the true lin-
eage and function of these cells, with some workers feeling that 
designations such as "histiocyte" are obsolete [16]. Recent studies 
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Figure 2. Electron micrograph of periodate/lysine/paraformaldehyde-
fixed frozen section of normal skin that had been reacted with HLA-DR 
antibody (L243) fo llowed by a peroxidase-anti peroxidase visualization tech-
nique. Note the two cells with dark reaction product on their surfaces (while 
bordered arrowheads) surrounding a microvesscl whose endothelial cells (lIt/-
bordered arrowheads) are not similarly decorated with reaction product. The 
possibility that the HLA-DR positive perivascular cells in this singly labeled 
preparation might be activated T cells rather than perivascular macrophages 
cannot be excluded, because similar cells having somewhat cerebriform 
nuclei in other preparations were occasionally found to express a human 
Thy-l determinant, 309 (data not shown). However, the large majority of 
HLA-DR positive, perivascular cells seen in this study had the appearance of 
the cell shown in Fig 3. Magnification: X5000. 
have suggested that at least some normally present, dermal, mono-
nuclear, dendritic cells do express class II antigens in situ [2,3]. 
While the function of such cells has not yet been formally exam-
ined, some workers have suggested that they might represent spe-
cialized fibroblasts and others have argued in favor of an antigen-
presenting cell phenotype. The double label immunofluorescence 
technique which we have used in the present study has allowed us to 
determine that many, if not the majority, of the cells of this type are 
not random.ly distributed through the dermis but share a rather 
intimate relationship with the dermal microvasculature. In addi-
tion, our studies suggest that the phenotype and ultrastructural 
characteristics of this cell are most compatible with a tissue macro-
phage. The possibility that they could represent a precursor stage of 
epidermal Langerhans cells has not been fully excluded; however, 
this seems unlikely. 
This dermal perivascular dendritic macrophage (DPDM) appears 
to be distinct from any previously described constitutive dermal cell 
type. Its dendritic morphology and rich endowment of HLA-D 
region antigens would at first glance suggest that it might represent 
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Figure 3. Ultrastructural characteristics of HLA-DR positive dermal perivascular cells in normal human skin. Ultrathin sections were prepared from 
Epon-embedded frozen sections which had been processed by the technique described in Fig 2 and the Materials arid Methods section. In addition, this section 
was counterstained with lead citrate to enhance cytoplasmic structural detail. Note the somewhat folded nucleus (white bordered arrowheads) and relatively 
dark cytoplasm containing several mitochondria (Imbordered arrowheads) . In other similar sections, an occasional lysosome was observed. Birbeck granules 
were not seen. The dark peroxidase reaction product in the plasma membrane which marks the presence ofHLA-DR antigen is not seen as distinctly here as in 
Fig 2 because of the lead citrate counterstaining. In other sections that were not stained , HLA-DR antibody binding was limited to the cell surface. 
Magnification: X26,OOO. 
a dermal precursor of the bone marrow-derived epidermal Langer-
hans cell . However, its macrophage phenotype, ultrastructural ap-
pearance, absence of CD1a (OKT-6) expression, and absence of 
Birbeck granules all argue against this possibility. The CD1 gene 
family (CD1a, CD1b, CD1c) is felt to possibly represent the human 
equivalent of the murine thymus lukemia-like or Qa antigen sys-
tems [17] . T he CD1a (OKT-6) determinant is expressed predomi-
nately on cortical thymocytes and epidermal Langerhans cells. The 
CD1c gene product was previously thought to have a relatively 
limited tissue distribution. However, recent human studies employ-
ing the M241 monoclonal antibody have found it to be expressed on 
normal circulating B cells [17] as well as a dendritic cell type nor-
mally found within the dermis [11]. This latter report has suggested 
that CD1c positive dermal dendritic cells are found predominately 
within the perivascular space. The perivascular dendritic cell that 
we have characterized does not express the CD1c determinant, as 
defined by the 7C6 monoclonal antibody. In addition, no dermal or 
epidermal cells were observed in our studies to express the CD1b 
determinant identified by monoclonal antibody 7C4. No other 
studies to date have reported CD1b positive cells within the skin. 
The macrophage phenotype and expression of all three major 
HLA-D region gene products by this cell coupled with its close 
relationship with the dermal microvasculature suggests the possibil-
ity that it might playa role in the immunobiology of the dermal 
microvascular unit. For the purpose of this discussion, the term 
"dermal microvascular unit" is used to refer to DMVEC and those 
other constitutive dermal cell types (e.g., DPDM, mast cells, peri-
cytes, and extravascular T cells), which share an intimate anatomical 
relationship with the microvessels of normal human skin. 
Recent studies by others have documented that T cells, some 
expressing activation markers, can also be found to surround dermal 
microvessels in normal skin [18].If the DPDM has antigen-present-
ing capabilities, its location would place it in an ideal position to 
interact with these perivascular T cells to generate protective im-
mune responses against antigens that might be delivered to this area 
from the circulation (e.g., infectious agents, drugs). In addition, this 
interaction could serve as a backup system for those antigens from 
th e external environment, especially complex ones that might re-
quire endocytic processing, which successfully breach the outer 
perimeter of the epidermal Langerhans cell network. Cytokines 
resulting from DPDM-triggered, perivascular T-cell activation 
could provoke an effector response by another member of the der-
mal microvascular unit, the mast cell , because this cell is known to 
be capable of responding to certain Iymphokines. Others have re-
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cently reported that Ia positive, bone marrow-derived, perivascular 
microglial cells might serve a similar antigen-presenting cell func-
tion within the central nervous system [1 9] . 
The expression ofHLA-D region antigens by tissue cells does not 
always correlate positively with antigen-presenting capabilities. 
While gamma-IF can stimulate dermal fibroblasts to express class II 
antigens, such cells do not function well in presenting antigen to 
unprimed T cells [20]. In addition, normal pulmonary alveolar mac-
rophages do express class II antigens; however, these cells have been 
found to be relatively poor antigen-presenting cells, related in part 
to their low capacity for IL-1 secretion and inability to effectively 
bind to T cells [21]. Hepatic Kupffer cells also are relatively defi-
cient in antigen-presenting capabilities [22]. It is thus possible that 
DPDM might also prove to be relatively inefficient antigen-
presenting cells. Studies are currently underway in our laboratory to 
isolate dermal macrophages in order to address this issue [23]. If this 
cell is also found to be relatively deficient in antigen-presenting 
capabilities, what then might be its physiologic significance? Re-
cent studies in our lab have documented that another cellular com-
ponent of the dermal microvascular unit, the microvascular endo-
thelial cell, does possess some antigen-presenting cell capabilities 
when stimulated with cytokines such as gamma interferon [24]. At 
least some of the many substances which are produced by macro-
phages, such as interleukin-l and tumor necrosis factor-a lpha, are 
capable of upregulating certain endothelial cell functions [data re-
viewed in Ref 25]. It is therefore possible that factors produced by 
DPDM might be capable of influencing the function of the dermal 
microvascular endothelial cells, including their abi lity to actively 
bind and stimulate circulating T cells. 
A number of inflammatory skin disorders (e.g., polymorphous 
light eruption, Jessner's lymphocytic infiltrate, morbilliform drug 
eruptions, cutaneous lupus erythematosus) have as a prominent 
component of their histopathology, a vasocentric pattern of infil-
trating mononuclear lymphoid cells. A better understanding of the 
immunologic functional interactions that can occur berween the 
cells of the dermal microvascular unit in normal skin could serve as a 
framework for further characterizing the pathophysiology of such 
clinical disorders. 
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